Healthcare-focused SPAC Sarissa Capital Acquisition in a preliminary proxy said it seeks a merger deadline extension from Oct. 23 to an indeterminate date in 2023.
The SPAC said it signed a non-binding letter of intent with an unnamed target last month.
Sarissa raised $175 million in an October 2020 IPO with a focus on companies in the healthcare sector.
The company’s sponsor, Sarissa Capital Acquisition Sponsor, was capitalized by investment funds managed by Sarissa Capital Management, which was founded by Alex Denner. Read more.
